Am J Dermatopathol

1. NICKLES M, Hunt S, Turcios-Escobar S, Babwah A, et al
   Richter Syndrome Presenting as Subcutaneous Nodules and a Dermal Plaque.
   Am J Dermatopathol. 2024;46:443-446.
   

   >> Share

   
   
2. SALAH H, Duran J, Russell MA, Gru AA, et al
   Apocrine Hidrocystoma of the Nail: A Unique Case.
   Am J Dermatopathol. 2024;46:433-435.
   

   >> Share

   
   
3. CARR RA, Wiggins J, Slater DN
   Follicular (Infundibular-Tricholemmal) Squamous Cell Carcinoma: A New WHO Entity. Clinicopathological Features in 103 Cases, Including Follow-Up and Implications for Patient Management.
   Am J Dermatopathol. 2024;46:416-432.
   

   >> Share

   
   
4. HASKOLOGLU S, Ozturk G, Deveci Demirbas N, Akal C, et al
   Junctional Epidermolysis Bullosa Linked to Homozygous Mutation in LAMC2 Gene: A Case Report With Eosinophil-Rich Inflammatory Infiltrate.
   Am J Dermatopathol. 2024;46:447-451.
   

   >> Share

   
   
5. HANLY A, Turner N, Ko CJ, Panse G, et al
   Spiny Keratoderma: Clinical and Histopathological Findings in a Series of 3 Cases.
   Am J Dermatopathol. 2024;46:439-442.
   

   >> Share

   
   
6. MARTINEZ-ORTEGA JI, Ortega-Valerio G, Ramirez-Cibrian AG
   Post-traumatic Bullous Pilomatrixoma Exploring the Pathogenesis.
   Am J Dermatopathol. 2024;46:436-438.
   

   >> Share

   
   

   
   BMC Cancer

7. JORIS S, Giron P, Olsen C, Seneca S, et al
   Identification of RAD17 as a candidate cancer predisposition gene in families with histories of pancreatic and breast cancers.
   BMC Cancer. 2024;24:723.
   

   >> Share

   
   
8. XU C, Sun L, Wang H, Sun J, et al
   Identifying the mechanism of polysaccharopeptide against breast cancer based on network pharmacology and experimental verification.
   BMC Cancer. 2024;24:726.
   

   >> Share

   
   
9. KANG Z, Jin Y, Yu H, Li S, et al
   Relative efficacy of antibody-drug conjugates and other anti-HER2 treatments on survival in HER2-positive advanced breast cancer: a systematic review and meta-analysis.
   BMC Cancer. 2024;24:708.
   

   >> Share

   
   
10. LI Y, Han D, Shen C
    Prediction of the axillary lymph-node metastatic burden of breast cancer by (18)F-FDG PET/CT-based radiomics.
    BMC Cancer. 2024;24:704.
    

    >> Share

    
    

    
    Br J Dermatol

11. BENCOMO T, Lee CS
    Gene expression landscape of cutaneous squamous cell carcinoma progression.
    Br J Dermatol. 2024 Jun 13:ljae249. doi: 10.1093.
    

    >> Share

    
    
12. BARBAROT S, Aubert H, Vibet MA, Leray M, et al
    Effectiveness of a nurse-led one-to-one education programme in addition to standard care in children with atopic dermatitis: a multicentre randomized control trial.
    Br J Dermatol. 2024 Jun 12:ljae111. doi: 10.1093.
    

    >> Share

    
    
13. FISCHER J
    Confetti Cure: Reversing the Genetic Kaleidoscope of Ichthyosis.
    Br J Dermatol. 2024 Jun 11:ljae248. doi: 10.1093.
    

    >> Share

    
    

    
    Cancer

14. YABROFF KR, Mittu K, Halpern MT
    Cost-of-care discussions for individuals with advanced non-small cell lung cancer and melanoma: Findings from a large, population-based pilot study.
    Cancer. 2024 Jun 13. doi: 10.1002/cncr.35380.
    

    >> Share

    
    
15. RUAN Y, Heer E, Brenner DR
    Reply to "National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough".
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35339.
    

    >> Share

    
    
16. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
    National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough.
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35335.
    

    >> Share

    
    

    
    Cancer Lett

17. LIU M, Zhao Z, Wang C, Sang S, et al
    Harnessing genetic interactions for prediction of immune checkpoint inhibitors response signature in cancer cells.
    Cancer Lett. 2024;594:216991.
    

    >> Share

    
    
18. BELLI S, Esposito D, Ascione CM, Messina F, et al
    EGFR and HER2 hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer.
    Cancer Lett. 2024 May 22:216968. doi: 10.1016/j.canlet.2024.216968.
    

    >> Share

    
    

    
    Clin Dermatol

19. GAGNA CE, Yodice AN, D'Amico J, Elkoulily L, et al
    Novel B-DNA dermatophyte assay for demonstration of canonical DNA in dermatophytes: Histopathologic characterization by artificial intelligence.
    Clin Dermatol. 2024;42:233-258.
    

    >> Share

    
    
20. ALHATEM A, Wong T, Clark Lambert W
    Revolutionizing diagnostic pathology: The emergence and impact of artificial intelligence-what doesn't kill you makes you stronger?
    Clin Dermatol. 2024;42:268-274.
    

    >> Share

    
    
21. CLARK LAMBERT W, Grzybowski A
    Dermatology and artificial intelligence.
    Clin Dermatol. 2024;42:207-209.
    

    >> Share

    
    
22. WILLIAMS-MEDINA E, Duarte-Bateman D, Chen Y, Bullock T, et al
    Higher Detection of Melanoma on the Back in Married Men.
    Clin Dermatol. 2024 Jun 11:S0738-081X(24)00084.
    

    >> Share

    
    

    
    Clin Exp Dermatol

23. LANZETTI M, Colantuono VA, Francalanci S, Massi D, et al
    Cutaneous Angiosarcoma arising over rhinophyma: an unusual variant of lymphedema-associated angiosarcoma?
    Clin Exp Dermatol. 2024 Jun 14:llae233. doi: 10.1093.
    

    >> Share

    
    
24. FERRUCCI S, Tavecchio S, Maronese CA, Balato A, et al
    Short-, mid- and long-term efficacy of dupilumab in moderate to severe atopic dermatitis: a real life multicenter Italian study on 2576 patients.
    Clin Exp Dermatol. 2024 Jun 11:llae208. doi: 10.1093.
    

    >> Share

    
    

    
    Int J Cancer

25. WANG Y, Cai W, He P, Cai Q, et al
    Clinical outcomes of coronavirus disease in patients with breast cancer treated with granulocyte colony-stimulating factor following chemotherapy: Triangulation of evidence using population-based cohort and Mendelian randomization analyses.
    Int J Cancer. 2024 Apr 1. doi: 10.1002/ijc.34914.
    

    >> Share

    
    

    
    Int J Dermatol

26. ZHAI S, Chen L, Liu H, Wang M, et al
    Skin barrier: new therapeutic targets for chronic kidney disease-associated pruritus - a narrative review.
    Int J Dermatol. 2024 Jun 10. doi: 10.1111/ijd.17254.
    

    >> Share

    
    
27. YADLAPATI S, Rosa-Nieves PM, Mehta N, Merritt BG, et al
    Treatment of sebaceous carcinoma with Mohs micrographic surgery versus wide local excision: a systematic review.
    Int J Dermatol. 2024 Jun 10. doi: 10.1111/ijd.17283.
    

    >> Share

    
    
28. JAALOUK D, Algarin YA, Pulumati A, Humeda J, et al
    Lasers for the treatment of nail psoriasis: a systematic review.
    Int J Dermatol. 2024 Jun 10. doi: 10.1111/ijd.17304.
    

    >> Share

    
    
29. LI Z, Hu B, Kang L, Zeng S, et al
    Different prognosis in cutaneous early-onset and late-onset Merkel cell carcinoma: a population-based retrospective study.
    Int J Dermatol. 2024 Jun 11. doi: 10.1111/ijd.17297.
    

    >> Share

    
    
30. JING FZ, Pazhava A, Todd A, Meves A, et al
    Statin use does not impact sentinel lymph node metastasis and recurrence in melanoma patients: an 844-patient retrospective study.
    Int J Dermatol. 2024 Jun 12. doi: 10.1111/ijd.17320.
    

    >> Share

    
    
31. PEREGO G, Aromolo IF, Barei F, Valtellini L, et al
    Effectiveness of dupilumab in atopic dermatitis on the head and neck: a single-center study on 553 patients.
    Int J Dermatol. 2024 Jun 14. doi: 10.1111/ijd.17278.
    

    >> Share

    
    

    
    J Cutan Pathol

32. PARK J, Greenblatt R, Fang V, Jariwala N, et al
    Blue onychomatricoma: Blue discoloration of an onychomatricoma secondary to pigmented onychomycosis.
    J Cutan Pathol. 2024;51:477-481.
    

    >> Share

    
    
33. HAYNES D, Haneke E, Rubin AI
    Clinical, onychoscopic, nail clipping, and histopathological findings of malignant onychopapilloma.
    J Cutan Pathol. 2024;51:500-505.
    

    >> Share

    
    
34. IBRAHEIM MK, Storey L, North JP
    Recurrent inverse necrotizing infundibular crystalline folliculitis.
    J Cutan Pathol. 2024;51:496-499.
    

    >> Share

    
    
35. THANASI H, Fabiano A, Baraldini V, Cattaneo E, et al
    Giant congenital fibroblastic connective tissue nevus associated with vascular anomalies.
    J Cutan Pathol. 2024;51:485-489.
    

    >> Share

    
    
36. DURGIN JS, Whittington CP, Joseph M, Harms PW, et al
    Multiple primary dermatofibrosarcoma protuberans tumors in a single patient with chromosomal microarray analysis: A case report and review.
    J Cutan Pathol. 2024;51:490-495.
    

    >> Share

    
    

    
    J Dermatol

37. HA GU, Kim JH, Ha DL, Lee H, et al
    Ultrasonographic evaluation of nail matrix topography for preservative nail surgery of nail unit melanoma.
    J Dermatol. 2024 Jun 14. doi: 10.1111/1346-8138.17340.
    

    >> Share

    
    
38. SUZUKI S, Kamata M, Ito M, Watanabe A, et al
    Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin-17 inhibitors in a patient with generalized pustular psoriasis: A case report.
    J Dermatol. 2024 Jun 14. doi: 10.1111/1346-8138.17337.
    

    >> Share

    
    
39. HIRAI Y, Sakurai J, Yoshida S, Kikuchi T, et al
    Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30-positive cutaneous T-cell lymphoma.
    J Dermatol. 2024 Jun 14. doi: 10.1111/1346-8138.17324.
    

    >> Share

    
    
40. KAWAMOTO M, Kawakami Y, Hirai Y, Kubota S, et al
    Disseminated Lomentospora prolificans infection presenting with multiple cutaneous lesions in an immunocompromised host: A case report and literature review.
    J Dermatol. 2024 Jun 12. doi: 10.1111/1346-8138.17322.
    

    >> Share

    
    
41. KOMATSU S, Kamiya T, Kato J, Uhara H, et al
    A small melanoma of the finger characterized predominantly by nest proliferation and a parallel furrow pattern.
    J Dermatol. 2024 Jun 11. doi: 10.1111/1346-8138.17332.
    

    >> Share

    
    
42. HEERFORDT IM, Framke E, Windfeld-Mathiasen J, Mogensen M, et al
    Reevaluating the role of interferon-beta in psoriasis pathogenesis: A registry-based self-controlled study.
    J Dermatol. 2024 Jun 11. doi: 10.1111/1346-8138.17338.
    

    >> Share

    
    

    
    J Invest Dermatol

43. LAMBERT KA, Clements CM, Mukherjee N, Pacheco TR, et al
    SASH1 S519N variant links skin hyperpigmentation and premature hair graying to dysfunction of melanocyte lineage.
    J Invest Dermatol. 2024 Jun 5:S0022-202X(24)00393.
    

    >> Share

    
    

    
    Lancet

44. KIMBALL AB, Jemec GBE, Sayed CJ, Kirby JS, et al
    Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
    Lancet. 2024 May 22:S0140-6736(24)00101-6. doi: 10.1016/S0140-6736(24)00101.
    

    >> Share

    
    
45. MOLINELLI E, Simonetti O
    Bimekizumab: dual inhibition as a promising tool in the management of hidradenitis suppurativa.
    Lancet. 2024;403:2457-2459.
    

    >> Share

    
    

    
    N Engl J Med

46. WANG J, Liu J
    Tuberculosis Verrucosa Cutis.
    N Engl J Med. 2024;390:e58.
    

    >> Share

    
    
47. MIDANI L, Ridgeway G, Phillips CM, Smidt AC, et al
    Inclusive Dermatology - Creating a Diverse Visual Atlas of Skin Conditions.
    N Engl J Med. 2024;390:2037-2038.
    

    >> Share

    
    
48. KOWDLEY KV, Levy C, Jones D
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. Reply.
    N Engl J Med. 2024;390:1935-1936.
    

    >> Share

    
    
49. HIRSCHFIELD GM, Kremer AE, Levy C
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. Reply.
    N Engl J Med. 2024;390:1934-1935.
    

    >> Share

    
    
50. IJICHI H
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:1934.
    

    >> Share

    
    
51. AREVALO-CANAS C, Arevalo-Serrano J
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:1933-1934.
    

    >> Share

    
    

    
    Plast Reconstr Surg

52. PAULUS VAA, van Raay SHC, Teunissen JS, Lese I, et al
    Skin Color Match in Autologous Breast Reconstruction: Which Donor Site Gives the Best Result?
    Plast Reconstr Surg. 2024 May 24. doi: 10.1097/PRS.0000000000011562.
    

    >> Share

    
    

    
    PLoS Genet

53. DENNIS M, Hurley A, Bray N, Cordero C, et al
    Her2 amplification, Rel-A, and Bach1 can influence APOBEC3A expression in breast cancer cells.
    PLoS Genet. 2024;20:e1011293.
    

    >> Share

    
    

    
    PLoS One

54. JEON HJ, Jeon HJ, Jeon SH
    Predicting the daily number of patients for allergic diseases using PM10 concentration based on spatiotemporal graph convolutional networks.
    PLoS One. 2024;19:e0304106.
    

    >> Share

    
    
55. NASCIMENTO LS, de Castro YS, Figueira JA, Souza RDC, et al
    Toxoplasma gondii infection and high levels of IgE are associated to erythema nodosum leprosy (ENL).
    PLoS One. 2024;19:e0300704.
    

    >> Share

    
    
56. AMADO MARTINS F, Almeida da Silva G, Ligeiro de Oliveira AP, Gutierrez Duran CC, et al
    Comparison between melatonin versus melatonin and photobiomodulation versus photobiomodulation in the treatment of Alopecia X in German Spitz dogs: Clinical, randomized, double-blind, parallel, non-inferiority protocol.
    PLoS One. 2024;19:e0304605.
    

    >> Share

    
    
57. TSENG TH, Chiang SC, Hsu JC, Ko Y, et al
    Cost-effectiveness analysis of granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced febrile neutropenia in patients with breast cancer in Taiwan.
    PLoS One. 2024;19:e0303294.
    

    >> Share

    
    
58. CHEN M, Wang F, Xie X, Yang X, et al
    Application of bundled process control in the prevention of pressure injury in patients with head and neck cancer.
    PLoS One. 2024;19:e0305190.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

59. DI LEO L, Pagliuca C, Kishk A, Rizza S, et al
    AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.
    Proc Natl Acad Sci U S A. 2024;121:e2400566121.
    

    >> Share

    
    
60. RUAN ML, Ni WX, Chu JCH, Lam TL, et al
    Iridium(III) carbene complexes as potent girdin inhibitors against metastatic cancers.
    Proc Natl Acad Sci U S A. 2024;121:e2316615121.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share